Delta 9 Cannabis Company Description
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company.
The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products.
Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products.
The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription.
The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia.
The company was incorporated in 2001 and is based in Vancouver, Canada.
![Delta 9 Cannabis logo](https://img.stockanalysis.com/logos1/TO/DN.png)
Country | Canada |
Founded | 2001 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 320 |
CEO | John Arbuthnot |
Contact Details
Address: 1066 West Hastings Street Vancouver, British Columbia V6E 3X1 Canada | |
Phone | 855 245 1259 |
Website | delta9.ca |
Stock Details
Ticker Symbol | DN |
Exchange | Toronto Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
ISIN Number | CA2477541049 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
John William Arbuthnot IV | Co-Founder, Chief Executive Officer and Director |
John William Arbuthnot III | Co-Founder and Director |
James Lawson | Chief Financial Officer, Controller and Secretary |
Mark Jonker | Chief Operations Officer |
Matthew Sodomsky | Chief Technology Officer |
Marshall Posner | Chief Marketing Officer |